Fanconi Anemia Complementation Group F Protein
"Fanconi Anemia Complementation Group F Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A Fanconi anemia complementation group protein. It is an essential component of a nuclear core complex that protects the GENOME against CHROMOSOMAL INSTABILITY. It interacts directly with FANCG PROTEIN and helps stabilize a complex with FANCA PROTEIN and FANCC PROTEIN.
| Descriptor ID |
D052219
|
| MeSH Number(s) |
D12.776.313.875 D12.776.660.293
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fanconi Anemia Complementation Group F Protein".
Below are MeSH descriptors whose meaning is more specific than "Fanconi Anemia Complementation Group F Protein".
This graph shows the total number of publications written about "Fanconi Anemia Complementation Group F Protein" by people in this website by year, and whether "Fanconi Anemia Complementation Group F Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fanconi Anemia Complementation Group F Protein" by people in Profiles.
-
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response. Cell Death Dis. 2019 09 11; 10(9):666.
-
Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers. Breast Cancer Res Treat. 2008 Sep; 111(1):113-20.
-
FANCF methylation contributes to chemoselectivity in ovarian cancer. Cancer Cell. 2003 May; 3(5):417-20.